So far this year, influenza cases are nearly 20 per cent higher than they were last year, and 2,800 cases were recorded in ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

The vaccine panel hand-selected by health secretary and anti-vaccine advocate Robert F. Kennedy Jr. on Thursday voted ...

When the seasonal flu strikes, most people expect the familiar lineup of fever, aches and congestion. But for many patients, dizziness emerges as an ...

While respiratory illnesses such as flu and cough affect Ugandans year-round, researchers have identified specific months ...

The Advisory Committee on Immunization Practices (ACIP), recently remade by Health and Human Services Secretary Robert F.

Both swine and avian influenza are strains of influenza A. Just as swine flu strains tend to infect pigs, avian flu strains ...

Moderna's messenger RNA flu vaccine candidate has shown has shown positive results in a late-stage trial. The biotechnology company said Monday its seasonal influenza vaccine candidate, mRNA-1010, ...